Poolbeg Pharma Plc Stock Performance
| POLBF Stock | USD 0.04 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Poolbeg Pharma are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Poolbeg Pharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Poolbeg Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Poolbeg |
Poolbeg Pharma Relative Risk vs. Return Landscape
If you would invest 4.25 in Poolbeg Pharma PLC on September 27, 2025 and sell it today you would earn a total of 0.00 from holding Poolbeg Pharma PLC or generate 0.0% return on investment over 90 days. Poolbeg Pharma PLC is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Poolbeg, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Poolbeg Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Poolbeg Pharma's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Poolbeg Pharma PLC, and traders can use it to determine the average amount a Poolbeg Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| POLBF |
Based on monthly moving average Poolbeg Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Poolbeg Pharma by adding Poolbeg Pharma to a well-diversified portfolio.
Poolbeg Pharma Fundamentals Growth
Poolbeg Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Poolbeg Pharma, and Poolbeg Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Poolbeg Pink Sheet performance.
| Shares Outstanding | 500 M | |||
| EBITDA | (3.24 M) | |||
| Cash And Equivalents | 18.89 M | |||
| Cash Per Share | 0.04 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (2.86 M) | |||
About Poolbeg Pharma Performance
By analyzing Poolbeg Pharma's fundamental ratios, stakeholders can gain valuable insights into Poolbeg Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Poolbeg Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Poolbeg Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom. Poolbeg Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 7 people.Things to note about Poolbeg Pharma PLC performance evaluation
Checking the ongoing alerts about Poolbeg Pharma for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Poolbeg Pharma PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Poolbeg Pharma PLC generated a negative expected return over the last 90 days | |
| Poolbeg Pharma PLC has some characteristics of a very speculative penny stock | |
| Poolbeg Pharma PLC has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (3.11 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Poolbeg Pharma PLC has accumulated about 18.89 M in cash with (2.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Poolbeg Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Poolbeg Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Poolbeg Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Poolbeg Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Poolbeg Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Poolbeg Pharma's pink sheet. These opinions can provide insight into Poolbeg Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Poolbeg Pink Sheet analysis
When running Poolbeg Pharma's price analysis, check to measure Poolbeg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poolbeg Pharma is operating at the current time. Most of Poolbeg Pharma's value examination focuses on studying past and present price action to predict the probability of Poolbeg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poolbeg Pharma's price. Additionally, you may evaluate how the addition of Poolbeg Pharma to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |